S
yncope is defined as the temporary loss of consciousness resulting from a reversible disturbance of cerebral function. It is characterized by a loss of consciousness because of a lack of cerebral blood flow; rapid or sudden onset; falls by the patient if he or she is not supported; and transient attacks. In children, it is most often benign, but may sometimes herald a more serious and potentially life-threatening cause.
Syncope is not an uncommon problem because it is estimated that 20% of all children will experience at least one episode of fainting before the end of adolescence (1) . Before the age of six years, syncope is unusual except in patients with seizure disorders, breath-holding episodes and primary cardiac dysrhythmias.
The main purpose of the present paper is to propose an evaluation scheme that will allow physicians involved in the care of children to differentiate the life-threatening causes of syncope with the potential for injury or sudden death from the common, more benign, neurally mediated syncope (NMS). Secondarily, this paper facilitates the identification of the patient with NMS who may benefit from medical therapy and distinguishes syncope from the more frequent noncardiac 'spells' of childhood.
CAUSES OF SYNCOPE
Syncope can be classified into three major categories: NMS, cardiovascular syncope and noncardiovascular syncope ( Table 1) . The second category represents only a small proportion of the cases of syncope, but it is responsible for most of the anxiety on the part of parents that surrounds the diagnosis of syncope due to its potentially life-threatening causes.
NMS, or vasovagal syncope, is the most common cause of syncope in young patients. It seems to be related to the beta-adrenergic hypersensitivity of baroreceptors in the Syncope in children is most often neurally mediated and usually has a natural history of spontaneous resolution or improvement. Syncope is defined as the temporary loss of consciousness resulting from a reversible disturbance of cerebral function. It is characterized by a loss of consciousness due to a lack of cerebral blood flow, rapid or sudden onset, falling of the patient, if not supported, and transiency of the attack. In children, it is most often benign, but may sometimes herald a more serious, potentially life-threatening cause. The main purpose of the present paper is to propose an evaluation scheme that will allow the physician involved in the care of children to differentiate the life-threatening causes of syncope with potential for injury or sudden death from the common, more benign neurally mediated syncope. Secondarily, the present article facilitates the identification of the patient with neurally mediated syncope who may benefit from medical therapy and distinguishes syncope from the more frequent noncardiac 'spells' of childhood. vessels and the mechanoreceptors of the left ventricle after subtle changes in postural tone, circulating volume or the direct release of catecholamine from higher cerebral centres. This hypersensitivity results in an efferent response consisting of peripheral alphaadrenergic withdrawal and enhanced parasympathetic tone. NMS is recognized by a constellation of signs and symptoms, beginning with a prodrome that lasts several seconds to minutes, progressing to a brief period of unconsciousness. The episode may be initiated by one of many provocative events that usually consist of emotional stress such as fear, anxiety or sudden change in posture. Other precipitating states include anemia, dehydration, hunger, physical exhaustion and a crowded or poorly ventilated environment. Premonitory symptoms include lightheadedness, dizziness, nausea, shortness of breath, pallor, diaphoresis and visual changes. Vasodepressor syncope that is associated with exercise has been well described in paediatric patients and most commonly occurs immediately after the termination of an activity.
Cardiac syncope is less common than NMS, but a thorough evaluation is required to ensure the detection of potentially life-threatening diagnoses and to provide accurate prognostic information. Cardiac causes can be separated into two categories: primary cardiac anomalies (right or left heart obstruction, pulmonary hypertension, cyanotic spells in cyanotic heart defects, hypertrophic or congestive cardiomyopathies); and arrhythmias that can lead to syncope in many conditions (long QT syndrome, Brugada syndrome Clinical features that suggest an underlying cardiac problem are listed in Table 2 .
CLINICAL EVALUATION AND INVESTIGATION
A thorough clinical evaluation, including history and physical examination, is the most important part of the investigation. The history usually indicates that the diagnosis is related to cardiac causes (Table 2) , NMS (prodrome, associated symptoms, triggering event) or noncardiac syncope (migraine, history of seizures, etc). A family history of syncope, cardiomyopathy or sudden death will direct the diagnosis towards potentially severe cardiac causes such as long QT syndrome and familial hypertrophic cardiomyopathy. As stated above, NMS that is associated with exercise does exist, but a more serious cardiac cause should always be eliminated in exerciserelated syncope.
The physical examination should include supine and standing blood pressures, and a complete cardiac examination with emphasis on the pulse rate, and clicks, gallops and murmurs that would reveal a cardiac pathology.
An electrocardiogram (ECG) should always be included in all initial evaluations of syncope in children. Emphasis should be placed on the QT interval and T wave morphology for evidence of long QT syndrome; voltage criteria that are consistant with left or right ventricular hypertrophy for the evaluation of obstructive cardiac lesions or cardiomyopathies; manifest pre-excitation of WPW; and bradycardia, pauses, conduction disturbances or ectopy. In cases in which an arrhythmia is suspected, a 24 h ambulatory monitor should be used to eliminate frequent ectopy, VT, supraventricular tachycardia, bradycardia, intermittent WPW, heart block or pauses.
In most cases, no further diagnostic tests are needed when the history, physical examination and ECG suggest NMS. However, further diagnostic work-up is required if the diagnosis is unclear or if any of the following conditions exist: exercise-induced syncope that occurs during exertion; chest pain that precedes an episode of fainting; seizure activity; recurrent syncope (more than two or three episodes); and an abnormal cardiac examination. An echocardiogram should be performed to rule out malformations or cardiomyopathies. The tilt-table test came into use as a method for the evaluation of syncope of unknown cause. Its use is controversial in paediatrics because several groups have demonstrated sensitivities of 43% to 57% and specificities of 83% to100% (5) (6) (7) (8) . The test usually confirms the diagnosis of NMS that is detected simply on the basis of history, physical examination and ECG. In cases of syncope of unknown origin, the goal of investigation is primarily to rule out lifethreatening causes rather than to diagnose NMS; therefore, echocardiography is more useful than the tilt-table test. The author reserves this test for suspected NMS in situations in which the first-line medical therapy failed to relieve symptoms. For exercise-induced syncope, an exercise stress test is mandatory to look for st-T wave changes that are associated with coronary insufficiency and catecholamine-sensitive dysrhythmias (9,10).
MANAGEMENT
In NMS, the first line of treatment is behaviour modification. Conservative therapy is mandatory because there is a tendency for children to grow out of the propensity for syncope. It has been suggested that resolution is related to the recognition of prodromal symptoms and early interventions. The patient is advised to avoid dehydration, long periods of standing and irregular mealtimes. Other simple measures include water and table salt intake to increase plasma volume. When syncope persists despite behavioural changes, medical therapy can be used and usually includes a beta-blocker or fludrocortisone. Further therapy is rarely required. Avoidance of potentially toxic drugs is the rule; however, disopyramide has been used with success in some cases (11) . Pacemaker therapy is rarely used.
For cardiac syncope, the therapy is usually more clearly defined and directed to the underlying cause. It includes beta-blocker therapy in cases of long QT syndrome, medical therapy for some forms of cardiomyopathy, surgical resection for cardiac obstructive lesions and pacemaker therapy for a sick sinus or heart block. An implantable defibrillator is rarely required in cases of ressuscitated cardiac arrest or high risk familial disease (such as long QT syndrome, Brugada syndrome and hypertrophic cardiomyopathy).
CONCLUSIONS
Syncope in children is most often neurally mediated and usually has a natural history of spontaneous resolution or improvement. Conservative measures should be tried before introducing pharmacotherapy. Cardiac syncope is potentially life-threatening and can usually be suspected after the use of simple evaluative measures, including history, physical examination and ECG.
